Close Menu

lymphoma

NEW YORK (GenomeWeb News) – Qiagen today announced two exclusive licensing deals aimed at developing companion diagnostic tests for glioblastoma, lymphoma, and other cancers.

Cancer Genetics said recently that it expects to launch at least two more array-based tests in its blood cancer and urogenital cancer franchises this year: a clinical assay for mantle cell lymphoma, and another, undisclosed test in the urogenital cancer space.

NEW YORK (GenomeWeb News) – Insight Genetics said Tuesday that it has been chosen by the National Cancer Institute to participate in the institute's Clinical Assay Development Program.

Diagnovus this week launched Engauge-Cancer-DLBCL, a gene expression assay designed to aid physicians with risk stratification and treatment of patients with diffuse large B-cell lymphoma.

Epizyme this week announced a collaboration with Eisai and Roche to develop an in vitro, PCR-based companion diagnostic test to help treat genetically defined lymphomas.

Researchers from Epizyme and elsewhere have reported that the company's investigational compound EPZ5687 targets and destroys lymphoma cells harboring mutations in EZH2, a type of histone-modifying enzyme.

NEW YORK (GenomeWeb News) – PrimeraDx has landed a grant from the National Cancer Institute to develop a gene expression profiling assay that can rapidly detect diffuse large B-Cell lymphoma (DLBCL) subgroups, making it easier to diagnose the disease, select treatment options, and predict the lik

NEW YORK (GenomeWeb News) – Researchers at Mayo Clinic and the University of Iowa have received an $11.5 million grant from the National Cancer Institute to fund translational and clinical projects focused on lymphoma, including genomics-based research.

Sequenta's sequencing assay to measure residual disease is now being tested in two clinical trials for mantle cell lymphoma.

NEW YORK (GenomeWeb News) – An international team led by investigators at the National Institutes of Health has identified new pathogenic pathways in a form of non-Hodgkin's lymphoma called Burk

Pages

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.